Assessing transferrin modification of liposomes by atomic force microscopy and transmission electron microscopy

被引:92
作者
Anabousi, S
Laue, M
Lehr, CM
Bakowsky, U
Ehrhardt, C [1 ]
机构
[1] Univ Dublin Trinity Coll, Sch Pharm Pharmaceut & Pharmaceut Technol, Dublin 2, Ireland
[2] Univ Saarland, Dept Biopharmaceut & Pharmaceut Technol, D-6600 Saarbrucken, Germany
[3] Univ Saarland, Fac Med, Dept Anat & Cell Biol, D-6650 Homburg, Germany
[4] Univ Marburg, Dept Pharmaceut Technol & Biopharm, Marburg, Germany
关键词
drug targeting; transferrin; atoinic force microscopy; transmission electron inicroscopy; anticancer therapy; liposomes;
D O I
10.1016/j.ejpb.2004.12.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Site-specific delivery of drugs and therapeutics can significantly reduce drug toxicity and increase the therapeutic effect. Transferrin (Tf) is one suitable ligand to be conjugated to drug delivery systems to achieve site-specific targeting, due to its specific binding to transferrin receptors (TfR), expressed oil several cell types of therapeutic interest. TfRs have been reported to be highly expressed on the surfaces of tumour cells and the well-characterised and efficient mechanism of internalisation of Tf has been exploited for the delivery of anticancer drugs, proteins. and therapeutic genes into primarily proliferating malignant cells. Liposomes are effective vehicles for drugs, genes and vaccines and can be easily modified with proteins, antibodies, and other appropriate ligands, resulting in attractive formulations for targeted drug delivery. In this study, we used atomic force microscopy (AFM) and transmission electron microscopy (TEM) to confirm the conjugation of Tf to liposomes by three different coupling methods. In addition, the conventional assays for quantification of protein amount (BCA) and phospholipid content (according to Steward) were performed. AFM and TEM were able to display Tf-molecules on the liposomal surfaces and can be routinely used to obtain additional visual information on the protein-drug carrier conjugation in a fast and reliable manner. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:295 / 303
页数:9
相关论文
共 22 条
[1]   COVALENT MODIFICATION OF SERUM TRANSFERRIN WITH PHOSPHOLIPID AND INCORPORATION INTO LIPOSOMAL MEMBRANES [J].
AFZELIUS, P ;
DEMANT, EJF ;
HANSEN, GH ;
JENSEN, PB .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 979 (02) :231-238
[2]   Characterization of the interactions between various hexadecylmannoside-phospholipid model membranes with the lectin Concanavalin A [J].
Bakowsky, U ;
Rettig, W ;
Bendas, G ;
Vogel, J ;
Bakowsky, H ;
Harnagea, C ;
Rothe, U .
PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2000, 2 (20) :4609-4614
[3]   Targetability of novel immunoliposomes prepared by a new antibody conjugation technique [J].
Bendas, G ;
Krause, A ;
Bakowsky, U ;
Vogel, J ;
Rothe, U .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 181 (01) :79-93
[4]   Enhanced gene delivery in vitro and in vivo by improved transferrin-lipoplexes [J].
de Ilarduya, CT ;
Arangoa, MA ;
Moreno-Aliaga, MJ ;
Düzgünes, N .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2002, 1561 (02) :209-221
[5]  
Derycke ASL, 2002, INT J ONCOL, V20, P181
[6]   Preparation of lectin-vicilin nanoparticle conjugates using the carbodiimide coupling technique [J].
Ezpeleta, I ;
Irache, JM ;
Stainmesse, S ;
Chabenat, C ;
Gueguen, J ;
Orecchioni, AM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 142 (02) :227-233
[7]  
FAULK WP, 1980, LANCET, V2, P390
[8]   ZERO-LENGTH CROSSLINKING PROCEDURE WITH THE USE OF ACTIVE ESTERS [J].
GRABAREK, Z ;
GERGELY, J .
ANALYTICAL BIOCHEMISTRY, 1990, 185 (01) :131-135
[9]   Targeting of the photocytotoxic compound AlPcS4 to HeLa cells by transferrin conjugated PEG-liposomes [J].
Gusens, A ;
Derycke, A ;
Missiaen, L ;
De Vos, D ;
Huwyler, J ;
Eberle, A ;
de Witte, P .
INTERNATIONAL JOURNAL OF CANCER, 2002, 101 (01) :78-85
[10]   Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo [J].
Ishida, O ;
Maruyama, K ;
Tanahashi, H ;
Iwatsuru, M ;
Sasaki, K ;
Eriguchi, M ;
Yanagie, H .
PHARMACEUTICAL RESEARCH, 2001, 18 (07) :1042-1048